Healthy Clinical Trial
Official title:
Effects of Including 30-s Sprints During Low-intensity Cycling Exercises During a Training Camp on Performance and Muscle/Blood Characterisitcs
Verified date | November 2020 |
Source | Inland Norway University of Applied Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To investigate the effects of Including 30-s sprints during low-intensity cycling exercises during a training camp on performance and muscle/blood characterisitcs in elite cyclists
Status | Completed |
Enrollment | 18 |
Est. completion date | December 23, 2017 |
Est. primary completion date | December 23, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - VO2max > 65ml/kg/min Exclusion Criteria: - VO2max < 65ml/kg/min - Average endurance training per week >10hrs/wk during the four weeks leading up to the study |
Country | Name | City | State |
---|---|---|---|
Norway | Inland Norway University of Applied Sciences | Lillehammer |
Lead Sponsor | Collaborator |
---|---|
Inland Norway University of Applied Sciences |
Norway,
Almquist NW, Ellefsen S, Sandbakk Ø, Rønnestad BR. Effects of including sprints during prolonged cycling on hormonal and muscular responses and recovery in elite cyclists. Scand J Med Sci Sports. 2020 Oct 28. doi: 10.1111/sms.13865. [Epub ahead of print] — View Citation
Almquist NW, Ettema G, Hopker J, Sandbakk Ø, Rønnestad BR. The Effect of 30-Second Sprints During Prolonged Exercise on Gross Efficiency, Electromyography, and Pedaling Technique in Elite Cyclists. Int J Sports Physiol Perform. 2019 Nov 5:1-9. doi: 10.1123/ijspp.2019-0367. [Epub ahead of print] — View Citation
Almquist NW, Løvlien I, Byrkjedal PT, Spencer M, Kristoffersen M, Skovereng K, Sandbakk Ø, Rønnestad BR. Effects of Including Sprints in One Weekly Low-Intensity Training Session During the Transition Period of Elite Cyclists. Front Physiol. 2020 Sep 11;11:1000. doi: 10.3389/fphys.2020.01000. eCollection 2020. — View Citation
Bellinger P. Functional Overreaching in Endurance Athletes: A Necessity or Cause for Concern? Sports Med. 2020 Jun;50(6):1059-1073. doi: 10.1007/s40279-020-01269-w. Review. — View Citation
Borg G, Hassmén P, Lagerström M. Perceived exertion related to heart rate and blood lactate during arm and leg exercise. Eur J Appl Physiol Occup Physiol. 1987;56(6):679-85. — View Citation
Brandt N, Gunnarsson TP, Hostrup M, Tybirk J, Nybo L, Pilegaard H, Bangsbo J. Impact of adrenaline and metabolic stress on exercise-induced intracellular signaling and PGC-1a mRNA response in human skeletal muscle. Physiol Rep. 2016 Jul;4(14). pii: e12844. doi: 10.14814/phy2.12844. — View Citation
Costill DL, Thomas R, Robergs RA, Pascoe D, Lambert C, Barr S, Fink WJ. Adaptations to swimming training: influence of training volume. Med Sci Sports Exerc. 1991 Mar;23(3):371-7. — View Citation
Coyle EF, Feltner ME, Kautz SA, Hamilton MT, Montain SJ, Baylor AM, Abraham LD, Petrek GW. Physiological and biomechanical factors associated with elite endurance cycling performance. Med Sci Sports Exerc. 1991 Jan;23(1):93-107. — View Citation
De Pauw K, Roelands B, Cheung SS, de Geus B, Rietjens G, Meeusen R. Guidelines to classify subject groups in sport-science research. Int J Sports Physiol Perform. 2013 Mar;8(2):111-22. Review. — View Citation
Faria EW, Parker DL, Faria IE. The science of cycling: physiology and training - part 1. Sports Med. 2005;35(4):285-312. Review. — View Citation
Fernández-García B, Pérez-Landaluce J, Rodríguez-Alonso M, Terrados N. Intensity of exercise during road race pro-cycling competition. Med Sci Sports Exerc. 2000 May;32(5):1002-6. — View Citation
Foster C. Monitoring training in athletes with reference to overtraining syndrome. Med Sci Sports Exerc. 1998 Jul;30(7):1164-8. — View Citation
Gunnarsson TP, Brandt N, Fiorenza M, Hostrup M, Pilegaard H, Bangsbo J. Inclusion of sprints in moderate intensity continuous training leads to muscle oxidative adaptations in trained individuals. Physiol Rep. 2019 Feb;7(4):e13976. doi: 10.14814/phy2.13976. — View Citation
Halson SL, Bridge MW, Meeusen R, Busschaert B, Gleeson M, Jones DA, Jeukendrup AE. Time course of performance changes and fatigue markers during intensified training in trained cyclists. J Appl Physiol (1985). 2002 Sep;93(3):947-56. — View Citation
Hawley JA, Stepto NK. Adaptations to training in endurance cyclists: implications for performance. Sports Med. 2001;31(7):511-20. Review. — View Citation
Hopkins WG, Marshall SW, Batterham AM, Hanin J. Progressive statistics for studies in sports medicine and exercise science. Med Sci Sports Exerc. 2009 Jan;41(1):3-13. doi: 10.1249/MSS.0b013e31818cb278. Review. — View Citation
Hostrup M, Bangsbo J. Limitations in intense exercise performance of athletes - effect of speed endurance training on ion handling and fatigue development. J Physiol. 2017 May 1;595(9):2897-2913. doi: 10.1113/JP273218. Epub 2016 Nov 16. Review. — View Citation
Jeukendrup AE, Craig NP, Hawley JA. The bioenergetics of World Class Cycling. J Sci Med Sport. 2000 Dec;3(4):414-33. Review. — View Citation
Jeukendrup AE, Hesselink MK, Snyder AC, Kuipers H, Keizer HA. Physiological changes in male competitive cyclists after two weeks of intensified training. Int J Sports Med. 1992 Oct;13(7):534-41. — View Citation
Joyner MJ, Coyle EF. Endurance exercise performance: the physiology of champions. J Physiol. 2008 Jan 1;586(1):35-44. Epub 2007 Sep 27. Review. — View Citation
Laursen PB, Shing CM, Peake JM, Coombes JS, Jenkins DG. Interval training program optimization in highly trained endurance cyclists. Med Sci Sports Exerc. 2002 Nov;34(11):1801-7. — View Citation
Le Meur Y, Louis J, Aubry A, Guéneron J, Pichon A, Schaal K, Corcuff JB, Hatem SN, Isnard R, Hausswirth C. Maximal exercise limitation in functionally overreached triathletes: role of cardiac adrenergic stimulation. J Appl Physiol (1985). 2014 Aug 1;117(3):214-22. doi: 10.1152/japplphysiol.00191.2014. Epub 2014 Jun 12. — View Citation
Le Meur Y, Pichon A, Schaal K, Schmitt L, Louis J, Gueneron J, Vidal PP, Hausswirth C. Evidence of parasympathetic hyperactivity in functionally overreached athletes. Med Sci Sports Exerc. 2013 Nov;45(11):2061-71. doi: 10.1249/MSS.0b013e3182980125. — View Citation
Lucía A, Chicharro JL, Pérez M, Serratosa L, Bandrés F, Legido JC. Reproductive function in male endurance athletes: sperm analysis and hormonal profile. J Appl Physiol (1985). 1996 Dec;81(6):2627-36. — View Citation
Lucía A, Hoyos J, Pardo J, Chicharro JL. Metabolic and neuromuscular adaptations to endurance training in professional cyclists: a longitudinal study. Jpn J Physiol. 2000 Jun;50(3):381-8. — View Citation
MacDougall JD, Hicks AL, MacDonald JR, McKelvie RS, Green HJ, Smith KM. Muscle performance and enzymatic adaptations to sprint interval training. J Appl Physiol (1985). 1998 Jun;84(6):2138-42. — View Citation
Manzi V, Iellamo F, Impellizzeri F, D'Ottavio S, Castagna C. Relation between individualized training impulses and performance in distance runners. Med Sci Sports Exerc. 2009 Nov;41(11):2090-6. doi: 10.1249/MSS.0b013e3181a6a959. — View Citation
Meinild Lundby AK, Jacobs RA, Gehrig S, de Leur J, Hauser M, Bonne TC, Flück D, Dandanell S, Kirk N, Kaech A, Ziegler U, Larsen S, Lundby C. Exercise training increases skeletal muscle mitochondrial volume density by enlargement of existing mitochondria and not de novo biogenesis. Acta Physiol (Oxf). 2018 Jan;222(1). doi: 10.1111/apha.12905. Epub 2017 Jul 6. — View Citation
Menaspà P, Quod M, Martin DT, Peiffer JJ, Abbiss CR. Physical Demands of Sprinting in Professional Road Cycling. Int J Sports Med. 2015 Nov;36(13):1058-62. doi: 10.1055/s-0035-1554697. Epub 2015 Aug 7. — View Citation
Padilla S, Mujika I, Cuesta G, Goiriena JJ. Level ground and uphill cycling ability in professional road cycling. Med Sci Sports Exerc. 1999 Jun;31(6):878-85. — View Citation
Saw AE, Halson SL, Mujika I. Monitoring Athletes during Training Camps: Observations and Translatable Strategies from Elite Road Cyclists and Swimmers. Sports (Basel). 2018 Jul 20;6(3). pii: E63. doi: 10.3390/sports6030063. — View Citation
Siebenmann C, Robach P, Jacobs RA, Rasmussen P, Nordsborg N, Diaz V, Christ A, Olsen NV, Maggiorini M, Lundby C. "Live high-train low" using normobaric hypoxia: a double-blinded, placebo-controlled study. J Appl Physiol (1985). 2012 Jan;112(1):106-17. doi: 10.1152/japplphysiol.00388.2011. Epub 2011 Oct 27. — View Citation
Sjøgaard G. Muscle morphology and metabolic potential in elite road cyclists during a season. Int J Sports Med. 1984 Oct;5(5):250-4. — View Citation
Skovgaard C, Almquist NW, Kvorning T, Christensen PM, Bangsbo J. Effect of tapering after a period of high-volume sprint interval training on running performance and muscular adaptations in moderately trained runners. J Appl Physiol (1985). 2018 Feb 1;124(2):259-267. doi: 10.1152/japplphysiol.00472.2017. Epub 2017 Sep 21. — View Citation
Skovgaard C, Brandt N, Pilegaard H, Bangsbo J. Combined speed endurance and endurance exercise amplify the exercise-induced PGC-1a and PDK4 mRNA response in trained human muscle. Physiol Rep. 2016 Jul;4(14). pii: e12864. doi: 10.14814/phy2.12864. — View Citation
Slivka DR, Hailes WS, Cuddy JS, Ruby BC. Effects of 21 days of intensified training on markers of overtraining. J Strength Cond Res. 2010 Oct;24(10):2604-12. doi: 10.1519/JSC.0b013e3181e8a4eb. — View Citation
Sylta O, Tønnessen E, Seiler S. From heart-rate data to training quantification: a comparison of 3 methods of training-intensity analysis. Int J Sports Physiol Perform. 2014 Jan;9(1):100-7. doi: 10.1123/IJSPP.2013-0298. — View Citation
Thomsen JK, Fogh-Andersen N, Bülow K, Devantier A. Blood and plasma volumes determined by carbon monoxide gas, 99mTc-labelled erythrocytes, 125I-albumin and the T 1824 technique. Scand J Clin Lab Invest. 1991 Apr;51(2):185-90. — View Citation
Valstad SA, von Heimburg E, Welde B, van den Tillaar R. Comparison of Long and Short High-Intensity Interval Exercise Bouts on Running Performance, Physiological and Perceptual Responses. Sports Med Int Open. 2017 Dec 18;2(1):E20-E27. doi: 10.1055/s-0043-124429. eCollection 2018 Jan. — View Citation
Zapico AG, Calderón FJ, Benito PJ, González CB, Parisi A, Pigozzi F, Di Salvo V. Evolution of physiological and haematological parameters with training load in elite male road cyclists: a longitudinal study. J Sports Med Phys Fitness. 2007 Jun;47(2):191-6. — View Citation
* Note: There are 40 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Training load | Training load calculated as time spent in different heart rate zones using the individualized TRIMP method | From four weeks prior to the intervention and throughout the study, an average of 52 days | |
Primary | Performance during a 5-minute all-out cycling test | Mean power output measured during a 5-minute all-out cycling test performed at the end of a ~2 hour long exercise protocol | Changes from before the intervention (T0) to immediately after the intervention (T2, after REC) | |
Secondary | Sprint performance | Mean power output measured during four consecutive 30-s maximal sprints | Changes from before the intervention (T0) to immediately after the intervention (T2, after REC) | |
Secondary | Maximal oxygen uptake | Maximal oxygen consumption measured during an incremental cycling exercise test to exhaustion | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Maximal aerobic power output | Maximal aerobic power output measured as mean power output during the last minute of an incremental cycling exercise test to exhaustion | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Gross efficiency (training camp) | Contribution of total energy turnover to power output in the fresh and fatigued state incremental cycling exercise test (with 5 minute steps) | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Gross efficiency (recovery/REC) | Contribution of total energy turnover to power output in the fresh and fatigued state incremental cycling exercise test (with 5 minute steps) | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Power output at lactate threshold (training camp) | Power output at 4 mmol blood lactate concentration measured during an incremental cycling exercise test (with 5 minute steps) | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Power output at lactate threshold (recovery/REC) | Power output at 4 mmol blood lactate concentration measured during an incremental cycling exercise test (with 5 minute steps) | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Fractional utilization of VO2max (incremental test) | Fractional utilization of VO2max measured at 4 mmol blood lactate concentrations measured during an incremental cycling exercise test (with 5 minute steps) | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Fractional utilization of VO2max (5-min test) | Fractional utilization of VO2max measured during the 5-min test | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Protein abundance in skeletal muscle | Protein abundances in m. vastus lateralis measured using western blotting | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Haemoglobin mass (training camp) | Hemoglobin mass measured using CO rebreathing (g) | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Haemoglobin mass (recovery/REC) | Hemoglobin mass measured using CO rebreathing (g) | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Blood volume (training camp) | Blood volume measured using CO rebreathing | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Blood volume (recovery/REC) | Blood volume measured using CO rebreathing | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Plasma volume (training camp) | Plasma volume measured using CO rebreathing | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Plasma volume (recovery/REC) | Plasma volume measured using CO rebreathing | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Red blood cell volume (training camp) | Red blood cell volume measured using CO rebreathing | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Red blood cell volume (recovery/REC) | Red blood cell volume measured using CO rebreathing | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Mean corposcular volume (training camp) | Mean corposcular volume measured using CO rebreathing | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Mean corposcular volume (recovery/REC) | Mean corposcular volume measured using CO rebreathing | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Hematocrit (training camp) | Hematocrit measured using centrifugation | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Hematocrit (recovery/REC) | Hematocrit measured using centrifugation | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Body mass (training camp) | Body mass (kg) measured using Dual-energy X-ray absorptiometry | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Body mass (recovery/REC) | Body mass (kg) measured using Dual-energy X-ray absorptiometry | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Enzyme activity in skeletal muscle | Enzyme activity in m. vastus lateralis measured using ELISA kits (I.e., CS and PFK) | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Lean body mass (training camp) | Lean body mass (kg) measured using Dual-energy X-ray absorptiometry | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Lean body mass (recovery/REC) | Lean body mass (kg) measured using Dual-energy X-ray absorptiometry | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Fat mass (training camp) | Fat mass (kg) measured using Dual-energy X-ray absorptiometry | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Fat mass (recovery/REC) | Fat mass (kg) measured using Dual-energy X-ray absorptiometry | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) | |
Secondary | Session rate of percieved exertion | Session rate of percieved exertion (sRPE) measured after each exercise involving sprints/control exercise using a 9-point scale ranging from "very, very demotivated" to "very, very motivated" (1 to 9) | Throughout the training camp (14 days) | |
Secondary | Stress-recovery state (training camp) | Recovery state of participants measured using Recovery-Stress Questionnaire for Athletes (RESTQ-36-R-Sport, 36 questions, 7-point scale ranging from 0/never to 6/always) | Changes from before the intervention (T0) to immediately after the training camp (T1) | |
Secondary | Stress-recovery state (recovery/REC) | Recovery state of participants measured using Recovery-Stress Questionnaire for Athletes (RESTQ-36-R-Sport, 36 questions, 7-point scale ranging from 0/never to 6/always) | Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |